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  Little is known about how lactating women accommodate for their increased 
glucose demands during fasting to avoid maternal hypoglycemia. The objective of this 
study is to determine whether lactating women conserve plasma glucose by reducing 
maternal glucose utilization by increasing utilization of FFA and ketone bodies and/or 
increasing gluconeogenesis and mammary gland hexoneogenesis. Six healthy exclusively 
breastfeeding women and six non-lactating controls were studied during a 42h of fast and 
during  6h of re-feeding. Glucose and protein kinetic parameters were measured using 
stable isotopes and GCMS and energy expenditure and substrate oxidation using indirect 
calorimetry. After 42h of fasting, milk production decreased by 16% but remained within 
normal range. Glucose, insulin and C-peptide concentrations decreased with the duration 
of fasting in both groups but were lower (P<0.05) in lactating women. Glucagon, FFA 
and β-hydroxybutyrate concentrations increased with fasting time (P<0.001) and were 
higher (P<0.0001) in lactating women during both fasting and re-feeding. During 42h of 
fasting, gluconeogenesis was higher in lactating women when compared to non-lactating 
controls (7.7±0.4 vs. 6.5±0.2 µmol⋅kg-1⋅min-1, P<0.05), while glycogenolysis was 
suppressed to similar value (0.4±0.1 vs. 0.9±0.2 µmol⋅kg-1⋅min-1, respectively). 
Mammary hexoneogenesis did not increase with the duration of fasting. Carbohydrate 
oxidation was lower and fat and protein oxidations higher (P<0.05) in lactating women. 
In summary, lactating women are at risk for hypoglycemia if fasting is extended beyond 
30h. The extra glucose demands of extended fasting during lactation appear to be 
compensated by increasing gluconeogenesis associated with ketosis, decreasing 
carbohydrate oxidation, and by increasing protein and FFA oxidations. 
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Introduction 
Using new techniques to measure gluconeogenesis in vivo, we (4, 12, 18, 30) and 
others (13, 15) demonstrated that, gluconeogenesis accounts for approximately 50% 
(ranging from 35 to 75%) of glucose production following an overnight fast. During 
carbohydrate absorption, plasma glucose and insulin concentrations increase 
simultaneously, but plasma glucose concentrations remain in a very narrow range in 
normal individuals. This fine control is mediated by glucose induced increase in plasma 
insulin, leading to increasing peripheral glucose utilization and glycogen synthesis, while 
hepatic glucose production is decreasing as a result of inhibited glycogenolysis (22). In 
contrast,  during fasting, plasma glucose and insulin concentrations decrease and plasma 
FFA, ketone bodies and glucagon concentrations increase (22) resulting in decreased 
glucose  utilization and/or  potentially increased glucose production to maintain 
euglycemia.  
During a 24 h fast, glucose production in lactating women was ~35% higher than 
in non-lactating women presumably to meet the substrate needs for lactose synthesis (30). 
The increase in glucose production was the result of increased glycogenolysis since 
gluconeogenesis was essentially identical to that of the non-lactating controls. Over the 
course of the 24 h fast, rates of lipolysis and β- oxidation of fatty acids, as reflected by 
glycerol flux and ketonemia, were similar to those of non-lactating controls suggesting a 
lack of “mechanism(s)” to reduce glucose utilization in lactating women. However, the 
contribution of plasma glucose to lactose production decreased from 80% to 60% as a 
result of an increase in hexoneogenesis within the breast (28).  
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Humans have limited hepatic glycogen storage capacity. After 40-42 h of fasting 
in men, the rate of glycogenolysis contributed only about 8% of total glucose production 
rate (13, 15). In our previous study, we did not see a difference in glucose storage rate 
between lactating and non-lactating women in response to feeding (30). By adding the 
extra demands imposed by lactation, we assume that beyond a 24 h fast, hepatic glycogen 
stores would be depleted more rapidly in the lactating than in the non-lactating women.  
Despite these new insights, we still do not know if or how lactating women adapt to their 
increased glucose demands during extended fasting to avoid maternal hypoglycemia. 
Therefore, we undertook the present studies to determine whether increasing the duration 
of fasting from 24 to 42 h in lactating women would result in: 1) increased glucose 
production via an increase in gluconeogenesis together with an increase in 
hexoneogenesis; 2) decreased glucose utilization by reducing milk production and/or 
maternal glucose utilization; and 3) increased utilization of FFA and ketone bodies.  
 
Materials and Methods 
Tracers. Sterile and pyrogen free [1-13C]glucose (99 atom%), [15N2]urea, [6,6-
2H2]glucose, [1-13C]leucine and 2H2O were purchased from Cambridge Isotope 
Laboratories (Andover, MA). 2H2O was administered orally without additional 
preparation.  The other isotopes except the 2H2O were tested again for sterility and 
pyrogenicity in the investigation pharmacy of Texas Children’s Hospital. The isotopes 
were dissolved in isotonic saline, and the solutions filtered through a 0.2 μm filter 
(Millipore Corp. Bedford, MA) into sterile syringes. The sterile solutions were prepared 
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less than 48 h before the study, and maintained at 4°C until just prior to their use, as 
previously described (30).  
Subjects. Following thorough review and approval by the IRB for Human Subjects and 
the General Clinical Research Center (GCRC) Advisory Committee at Baylor College of 
Medicine, written consent was obtained from each of the subjects. All subjects were 
determined healthy if they had a normal physical examination, fasting blood glucose, 
hemoglobin (Hb), HbA1c and liver function tests. None of the women had a history of 
gestational diabetes or had children, parents, siblings or grandparents with diabetes. 
Except for routine postpartum vitamins and mineral supplements prescribed by their 
physician, none was on any medications including birth control pills. All women studied 
had a negative pregnancy test at the time of study. To exclude any pregnancy related 
changes in body composition and hormones and to ensure a stable physiologic model, all 
lactating women were studied between 6 and 12 wk post partum. No attempt was made to 
study the non-lactating women at a specific time in their menstrual cycle.  
No attempt was made to select subjects on the basis of ethnicity. As a result, six  
healthy lactating women [age 26.8 ± 1.2 y, (BMI) 22.7 ± 0.9 kg/m2, height 159.8 ± 2.8 
cm, weight 58.8 ± 3.2 kg, and lean body mass (LBM) 38.8 ± 2.1 kg, 4 Caucasian and 2 
Hispanic American and their healthy infants] and six (6) healthy, non-pregnant, non-
lactating controls [age 27.9 ± 2.1 y, BMI 21.8 ± 0.7 kg/m2 , Height 162.4 ± 1.4 cm, 
Weight 56.6 ± 1.9 kg, and LBM  39.0 ± 1.4 kg, 2 Caucasian, 2 African-American, 1 
American-Hispanic and 1 Asian American] were recruited for the study. The infants of 
the lactating women weighed 5.69 ± 0.36 kg and were 11.0 ± 0.5 wk of age at the time of 
study. 
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Study design. Women were instructed to consume a diet providing approximately 50% 
carbohydrate, 15% protein and 35% fat for the week prior to admission. Lactating women 
were asked to bring 6 to 10 oz of breast milk to supplement their infants feeding should 
they have technical difficulty with breastfeeding and/or decreased milk production. Each 
woman and her infant were admitted to the GCRC before 4 PM on the afternoon prior to 
study (day 1). At 5 PM, one intravenous (IV) catheter was introduced in the woman’s 
antecubital fossa or forearm vein under Emla® cream (Astra Pharmaceuticals, Wayne, 
PA) analgesia for blood sampling. Subjects were fed a supper meal of 10 kcal/kg at 6 PM 
and were subsequently fasted except for water ad libitum until the re-feeding portion of 
the protocol. Blood and milk samples were obtained at 6 PM and subsequently every 6 h 
until midnight on the last day of the study (day 3). Glucose concentrations were measured 
immediately at each blood draw. If the glucose decreased to < 60 mg/dL, an investigator 
was contacted and the frequency of glucose monitoring was increased. In addition, the 
mothers were carefully observed and at any signs and/or symptoms consistent with 
hypoglycemia, plasma glucose was immediately measured. If the glucose concentration 
decreased to < 40 mg/dL on a quantitative laboratory measure, the fast was terminated. 
The mothers were requested to breast-feed their infants every 3 h. At each feeding, the 
infants were fed from both breasts. Infants were weighed before and after each breast-
feeding to determine the volume of milk consumed (2, 19). Following each feeding the 
mothers emptied their breasts completely using a standard electric breast pump (Playtex 
Embrace™, Dover, DE). The weight of the resulting milk was measured and an aliquot 
frozen for subsequent analysis. This volume of milk was added to that consumed by the 
infant at each breast-feeding to determine total milk production (2). 
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At 8 PM day1, a second IV was established in the opposite arm under Emla® 
cream (Astra Pharmaceuticals, Wayne, PA) analgesia for infusions. Between 8 PM and 9 
AM, a primed-constant rate intravenous infusion of [15N2]urea (8 μmol/kg, 0.13 
µmol/kg.min) was administered to measure urea rate of appearance. Between 6 AM and 9 
AM, the subjects received a primed - constant rate intravenous infusion of [1-13C]leucine 
(4 μmol/kg, 0.06 µmol/kg.min) to measure leucine rate of appearance. Between 6 AM 
and 1 PM, the subjects received a primed - constant rate intravenous infusion of [1-
13C]glucose (20 μmol/kg and 0.33 µmol/kg.min) to measure glucose rates of appearance 
and production and the fractions of milk lactose sugars derived from plasma and 
mammary gland synthesis (25, 29). Blood samples (2.5 mL each) were obtained every 10 
min during the last half-hour of the initial three-hour glucose tracer infusion period (t = -
30 to t = 0 min).  At 9 AM, following the 0 min blood sample, an iv bolus of glucose, 
0.30 g/kg containing 10% [6,6-2H2]glucose (SLIVGTT) was administered over 90–120 
seconds and blood samples (2.5 mL each) were obtained at +2, 3, 4, 5, 8, 10, 18, 20, 28, 
32, 40, 60, 120, 180, 240 min. Indirect calorimetry was performed 3 times between 6 AM 
and 9 AM (0 time for the SLIVGTT). Following completion of the SLIVGTT, one of the 
venous access sites was removed while the second one was maintained for the duration of 
the study.   
Beginning at 11 PM of the 2nd day of admission (at 28 h of fasting), the women 
consumed 4 doses of 2H2O at 2 h intervals corresponding to a total dose of 3 g/kg. At 4 
AM, 2 additional intravenous catheters were introduced in the mother’s antecubital fossa 
or forearm vein under Emla® cream analgesia, for isotope infusion and a back-up line for 
blood sampling, if needed. At 6 AM, the subjects received primed constant rate infusions 
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of [6,6-2H2]glucose (9 μmol/kg, 0.14 μmol·kg-1·min-1), [15N2]urea (8 μmol/kg , 0.13 
μmol·kg-1·min-1) and [1-13C]leucine (4 μmol/kg , 0.06 μmol·kg-1·min-1). Blood samples 
(6-10 ml) were collected at 60 min intervals beginning at 6 AM until 6 PM. Milk samples 
were collected every 3 h from 6 AM through 6 PM. From noon until 6 PM, subjects were 
re-fed a ~70 kcal (~70 ml) non-galactose containing nutrient drink, Boost HPl® (Mead 
Johnson) (formally Sustacal®) every 30 min. This provided ~840 kcal or approximately 
50% of their daily requirements over the 6 h of feeding (assuming 12 h of feeding and 12 
h of fasting per day, thus, the adult 60 kg subject received ~1700 kcal/day). The purpose 
of this feeding strategy was to evaluate the subject’s acute response to re-feeding not to 
provide full caloric requirements. To avoid problems in data interpretation, both lactating 
and control subjects received the same caloric load of Boost HP®. CO2 production and 
O2 consumption were measured every 3 h from 6 AM through 6 PM using indirect 
calorimetry for calculation of substrate oxidations.  12 h urine collections were obtained 
during the first 36 h of the study followed by 6 h collections during the last 12 h. During 
collection, the urine was kept refrigerated and then frozen at -80 °C until nitrogen 
analyses and pH measurements were performed.  Non-lactating women were studied 
using an identical protocol except no breast milk samples were obviously obtained.  
Substrate and hormones determinations. Plasma glucose and lactate concentrations were 
determined using enzyme specific methods (YSI Glucose Analyzer, Yellow Springs, 
OH). Plasma insulin and C-peptide concentrations were measured using commercially 
available radioimmunoassay kits (Linco Research, Inc, St. Charles, MO). Plasma FFA 
and β-hydroxybutyrate concentrations were determined by microfluorometric enzyme 
analyses using Cobas Fara II Analyzer (Roche Diagnostic Systems, Inc., Montclair, NJ). 
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Blood urea nitrogen (BUN) concentration was measured calorimetrically using the Vitros 
analyzer (Ortho-Clinical Diagnostics, Rochester, NY). Plasma α-ketoisocaproate (α-
KIC) concentrations were determined by GCMS and reverse isotope dilution using 
[2H7]KIC as an internal standard (27). Lactose was hydrolyzed to glucose and galactose 
enzymatically and the resultant sugars analyzed individually as previously described (25, 
28). Milk lactose concentration was determined using an enzyme specific method (YSI 
Glucose Analyzer, Yellow Springs, OH). The concentration of protein was determined 
using Bicinchoninic Acid (BCA) protein assay kit (Novagen, Madison, USA) (14, 18). 
Urine pH was measured using a pH meter (Accumet Basic pH meter, Fisher Scientific, 
USA).  
Determination of isotope enrichments. [1-13C]glucose and  [6, 6-2H2]glucose were 
converted to the pentaacetate derivative and the enrichments of 13C and  2H2 were 
measured using GC-C-IRMS and GCMS, respectively (29). The [15N2]urea enrichment 
was determined using the 2-pyrimidinol-tert-butyldimethylsilyl  derivative as previously 
described  (11, 27). Plasma α-[1-13C]KIC enrichment was measured after derivatization 
to the oxime-tert-butyldimethylsilyl (TBDMS) derivative of α-KIC as previously 
described (27). During the intravenous infusion of compounds labeled with stable 
isotopes (36-48 h), the fraction of glucose derived from gluconeogenesis was measured 
as previously described (4). Briefly, 2H2O enrichment was measured using IRMS (4). The 
2H enrichment of glucose excluding C-2 was determined using the recently described 
method of Chacko, et al, (4).  
Indirect calorimetry. Indirect calorimetry was performed using a MedGraphic Model 
Indirect Calorimeter (MedGraphics Inc., Minneapolis, Minnesota). Substrate oxidation 
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rates for protein, glucose, lipid and resting energy expenditure were calculated using the 
gaseous exchange equations previously described (7). The substrate oxidation rates were 
calculated as: 
Lipid oxidation = 1.67 (VCO2 - VO2) - 1.92N 
Glucose oxidation = 4.55 VCO2 - 3.21 VO2 - 2.87N 
Protein oxidation = N / 6.25 
where VCO2 and VO2 are the L/min of gaseous exchange obtained from the calorimeter; 
N represents total nitrogen excretion (g/min) estimated from the urea Ra. 
Calculations: 
Total glucose entry and glucose production.  The total rate of appearance (Ra) of 
glucose into the systemic circulation was calculated under near steady-state condition 
using the standard isotope dilution equation:  
Ra-total = [Ei/Ep] × I 
where Ei and Ep are the infusate and plasma enrichments, respectively, of the labeled 
glucose ([1-13C] following 14 h fasting and [6, 6-2H2] following 42 h fasting and re-
feeding) and I is the rate of infusion of the labeled glucose.  
In the fasting state, glucose production rate (GPR) was calculated by subtracting the 
amount of infused labeled glucose from the glucose Ra: 
GPR = Ra-total - I 
GPR is the sum of the rates of gluconeogenesis (GNG) and glycogenolysis: 
GPR = GNG + Glycogenolysis 
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The fraction of glucose derived from gluconeogenesis (GNG) was determined using 
2H2O and the average 2H enrichments of carbons 1,3,4,5,and 6 of glucose as recently 
described using the following formula (4):  
Fractional GNG = [(M+1)2H (m/z 169)/6] / 2H2O 
where (M+1)2H (m/z 169) is the M+1 enrichment of 2H glucose measured using the m/z 
170/169 fragment of glucose divided by 6, the number of 2H labeling sites on the m/z 169 
fragment of glucose and 2H2O is the enrichment of deuterium in body water (4).  
The rate of gluconeogenesis is: 
GNG = Fractional GNG × Ra-total  
The rate of glycogenolysis in the post absorptive state was calculated as the difference 
between glucose production and gluconeogenesis: 
Glycogenolysisfasting = GPR – GNG. 
During meal ingestion, the rate of appearance of dietary glucose into the plasma 
pool (Ra-meal) was estimated from the carbohydrate content in the Boost® drink. We 
assumed that ~ 85% of orally ingested glucose entered the systemic circulation in the 
normal volunteer adults based on our previous studies (i.e. ~14g × 0.85/100 ml of drink 
consumed) (30).  
The rate of glycogenolysis during meal absorption was estimated as: 
Glycogenolysis feed = Ra-total – (GNG + Ra-meal + I) 
The fraction of glucose and galactose (product pool) in milk lactose that was derived 
from plasma glucose (precursor pool) and the fraction derived from de novo synthesis 
were calculated as previously described (25, 30). 
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Urea production rate. The rate of appearance of urea into the systemic circulation was 
calculated under near steady-state condition using the standard isotope dilution equation:  
Ra-urea = [(Ei/Ep) -1] × I 
where Ei and Ep are the infusate and plasma enrichments, respectively, of the labeled urea 
and  I is the rate of infusion of the labeled urea (27).   
Rates of protein oxidation.  Based on urea Ra, protein oxidation was calculated using the 
following equation: 
Protein oxidation (g⋅kg-1⋅d-1) = Urea Ra × 0.47 × 6.25 
Where Urea Ra is expressed in g⋅kg-1⋅d-1 and 0.47 is the fraction of urea that is composed 
of nitrogen and 6.25 is the inverse of the fraction of nitrogen in protein. 
Rate of proteolysis. Leucine appearance rate (Ra-Leu) was used as an indicator of 
proteolysis and was calculated using the reciprocal pool model using the [1-13C]KIC 
enrichment according to the following equation. 
Ra-Leu =  [(Ei/Ep) -1]  × I 
where Ei and Ep are the enrichments of the leucine infusate and plasma KIC, respectively, 
and I is the rate of infusion of the labeled leucine. The rate of proteolysis (g⋅kg-1⋅d-1) was 
calculated using the following equation as previously described (27) :  
Proteolysis = Ra-Leu  × 131 × 1440 × 10-6 × 12.5  
where Ra-Leu is leucine rate of appearance (µmol⋅kg-1⋅min-1), 131 is its molecular weight, 
1440 is to convert min to day, 10-6  is to convert µg to g and 12.5 is the inverse of leucine 
content in body protein (~8%).  
During fasting, proteolysis is derived solely from endogenous sources, while 
during feeding, it is the sum of the rate of entry of leucine from both endogenous and 
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exogenous sources. Endogenous leucine entry can be calculated by subtracting 
exogenous leucine entry from total leucine Ra. The exogenous leucine entry was 
calculated based on the content of protein in the Sustacal drink as provided by 
manufacturer (27). 
The rate of protein synthesis was calculated using the following equation: 
Proteolysis – Protein oxidation = Protein synthesis. 
Insulin sensitivity. Insulin sensitivity in the fasting condition was calculated using the 
averaged baseline insulin and glucose values using the HOMAR and QUICKI methods 
(5) according to the following formulae: 
  HOMAR = [glucose (mM) × insulin (μU/mL)]/22.5 
  QUICKI = 1/[log glucose (mg/dL) +  log insulin (μU/mL)]  
Insulin sensitivity and the first and second phase insulin secretory indices were calculated 
from the stable label intravenous glucose tolerance test (SLIVGTT) as previously 
described (29). 
Statistical analysis. Values obtained during the steady state periods were averaged for 
each subject and are presented as mean ± SE. Data between groups were compared using 
non-paired Student’s t-test, while data within the same group were compared using paired 
Student’s t-test. Changes in substrate and hormone concentrations and urine pH over time 
within and between groups were assessed using repeated-measures analysis of variance 
(ANOVA). Software programs SPSS (version 16; SPSS Inc, Chicago, IL) and Graph Pad 
Prism (version 4; GraphPad Software Inc, CA, USA) were used for all statistical 




Changes in substrate and hormone concentrations over time. Statistics were carried out 
using repeated measures ANOVA to demonstrate differences over time, differences 
between groups (non-lactating vs. lactating), and differences due to interaction of group 
and time (Figures 1-2). Repeated measures ANOVA revealed a progressive decrease in 
the plasma glucose concentration in both groups (P < 0.001) with fasting time. The 
decrease was greater (P < 0.0001) in the lactating as compared to the non-lactating 
women (Figure 1). During re-feeding, plasma glucose rose in both groups (P < 0.001) but 
was not different between the two groups (P = 0.09).  
Insulin and C-peptide concentrations followed the same pattern as glucose i.e. 
decreasing with the duration of the fasting and increasing (P < 0.0001) in the re-feeding 
period.  However, only insulin was lower in the lactating (P < 0.01) compared to the non-
lactating women during re-feeding (but not during fasting). In contrast, plasma glucagon 
concentrations increased with fasting (P < 0.0001) and were higher (P < 0.0001) in the 
lactating when compared to the non-lactating women. Re-feeding lowered glucagon 
concentration (P < 0.0001) but, the lactating women continued to have higher values (P < 
0.001) than the non-lactating controls (Figure 1). 
Lactate concentration fell with time (P < 0.0001) in both non-lactating controls 
and lactating women (Figure 2). During re-feeding, the plasma lactate concentration 
increased (P < 0.01) in the non-lactating while it decreased (P < 0.01) in the lactating 
women. BUN concentrations were higher (P < 0.0001) in the lactating group during both 
fasting and re-feeding. FFA concentrations and β-hydroxybutyrate were higher (P < 
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Figure 1. Mean ± SEM concentrations of plasma glucose, insulin, C-peptide and 
glucagon in the non-lactating (  ) (n = 6) and lactating (n = 6) (  ) women during the 
fasting (left panel) and re-feeding (right panel) states. Statistics were carried out using 
repeated measures ANOVA denoting differences overtime (A) and differences between 
groups (B) and difference due to interaction of group and time (AB). 
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 Figure 2. Mean ± SEM plasma concentrations of lactate; BUN = blood urea nitrogen; 
FFA = free fatty acids; β-OH-BT = β-hydroxybutyrate in the non-lactating (  ) (n = 6) 
and lactating (  ) (n = 6) women during fasting and re-feeding. Statistics were carried 
out using repeated measures ANOVA denoting differences over time (A), differences 
between groups (B) and difference due to interaction of group and time (AB). 
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Plasma substrate and hormone concentrations at specific time points: 
Plasma substrate concentrations. After 14 h of fasting, the plasma glucose 
concentrations were slightly lower in the lactating as compared to the non-lactating 
women (4.3 ± 0.1 vs. 4.6 ± 0.1, P = 0.04). Plasma lactate concentrations were also lower 
in the lactating group, whereas FFA, β-hydroxybutyrate, KIC and BUN were not 
different (Table 1). 
Table 1.  Average substrate and hormone concentrations during near steady states. 
 14 h-Fast 42 h-Fast Re-feeding 
 Non-lactating Lactating Non-lactating Lactating Non-lactating Lactating 
Glucose  (mM)   4.6 ± 0.1    4.3 ± 0.1*   3.6 ± 0.2     2.6 ± 0.1**    5.8 ± 0.3     6.7 ± 0.3 
Insulin (µU/mL)   5.0 ± 0.6    3.8 ± 0.7   2.0 ± 0.3     2.3 ± 0.5  40.8 ± 6.1   31.7 ± 4.8 
C-peptide (ng /mL)   1.4 ± 0.1    1.1 ± 0.1   0.6 ± 0.1     0.8 ± 0.1    6.5 ± 0.7     8.4 ± 1.3 
Glucagon (pg/ mL) 47.7 ± 4.3  53.9 ± 4.3 70.7 ± 3.3 118.6 ± 18.5*  50.6 ± 7.2   57.4 ± 2.7 
Lactate (mM)   1.0 ± 0.1    0.7 ± 0.0*   1.1 ± 0.1     1.2 ± 0.1    1.9 ± 0.2     1.0 ± 0.0** 
β-OH-BT (mM)   0.1 ± 0.1    0.3 ± 0.1   2.0 ± 0.4     4.3 ± 0.4**    0.1 ± 0.0     0.5 ± 0.3 
FFA (mM)   0.5 ± 0.1    0.7 ± 0.1   1.5 ± 0.3     2.0 ± 0.2*    0.2 ± 0.0     0.6 ± 0.1** 
BUN (mg/dL) 11.0 ± 1.0  13.0 ± 1.1 10.4 ± 0.7   14.3 ± 1.1*  13.2 ± 0.5    16.8 ± 0.6** 
α-KIC (µM) 30.7 ± 1.6  33.2 ± 3.1 50.9 ± 3.7   46.3 ± 7.3  47.9 ± 3.1   58.5 ± 7.9 
 
n = 6 subjects in each group. Values are mean ± SEM. β-OH-BT = β-hydroxybutyrate; 
FFA = free fatty acids; BUN = blood urea nitrogen; KIC = ketoisocaproic acid. * P (non- 
paired) < 0.05, ** P (non- paired) < 0.01, non-lactating (n = 6) vs. lactating (n = 6) 
women. Statistics related to the effect of fasting or feeding time on different parameters 
are presented in Figures 1-2.     
 
After 42 h of fasting, plasma glucose concentrations in lactating women remained 
lower than in non-lactating women (2.6 ± 0.1 vs. 3.6 ± 0.2 mM, P = 0.0002), 
respectively. No difference in plasma lactate or KIC concentrations was observed 
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between the two groups, whereas both plasma β-hydroxybutyrate (4.3 ± 0.4 vs. 2.0 ± 0.4 
mM, P = 0.007) and FFA (2.0 ± 0.2 vs. 1.5 ± 0.3, P = 0.04) were higher in lactating 
women. BUN concentrations were also higher in the lactating group (14.3 ± 1.1 vs. 10.4 
± 0.7 mg/dl, P < 0.05) (Table 1).  
After 6 h of re-feeding, plasma concentration of glucose were not different 
between lactating and non-lactating women while plasma lactate concentrations were 
nearly twice as high (P < 0.01) in the non-lactating as compared to the lactating women. 
Although plasma β-hydroxybutyrate and FFA concentrations decreased after re-feeding, 
FFA concentrations were three times higher in the lactating group (0.6 ± 0.1 vs. 0.2 ± 0.0 
mM, P = 0.005) by the end of the study. Plasma KIC concentrations were not different, 
but BUN concentrations were higher in the lactating group (16.8 ± 0.6 vs. 13.2 ± 0.5 
mg/dL, P < 0.01) (Table 1).  
Hormone concentrations and insulin sensitivity. After the overnight fast, plasma insulin, 
C-peptide and glucagon were not different between the two groups (Table 1). After 42 h 
of fasting, insulin and C-peptide concentrations were not different between lactating and 
non-lactating groups. However, the plasma glucagon concentration was higher in the 
lactating women (119 ± 19 vs. 71 ± 3 pg/ml, P < 0.05). After 6 h of re-feeding, plasma 
concentration of insulin, C-peptide and glucagon concentrations were not different 
between the two groups.  
After the overnight fast, insulin sensitivity as measured by HOMA (1.04 ± 0.13 
vs. 0.73 ± 0.15, P = 0.16) and QUICKI (0.38 ± 0.06 vs. 0.42 ± 0.1, P = 0.12) were not 
different between the non-lactating and lactating groups, respectively. Using SLIVGTT, 
insulin sensitivity (min-1)/ (µU·ml-1) (5.5 ± 1.1×10-4 vs. 8.9 ± 1.6×10-4) did not differ (P = 
 112
0.10 two sided, P = 0.05 one sided) between the non-lactating and the lactating groups. 
First phase (ф1 × 10-9) (335 ± 54 vs. 356 ± 74, P = 0.80) and second phase (ф2 × 10-9) 
(13.9 ± 1.7 vs. 10.9 ± 1.8, P = 0.26) insulin secretory indices also were not different 
between the lactating and non-lactating groups.  
Glucose kinetics. After the overnight fast, GPR was higher in the lactating as compared 
to the non-lactating women, respectively (13.3 ± 0.8 vs. 10.5 ± 0.3 µmol⋅kg-1⋅min-1, P = 
0.002) (Figure 3).  After 42 h of fast, GPR decreased (P < 0.01) to 8.1 ± 0.5 and 7.4 ± 
0.2 µmol⋅kg-1⋅min-1 in the lactating and non-lactating groups, respectively, but was no 
longer different between the two groups. The rates of gluconeogenesis were higher in 
lactating than non-lactating women (7.7 ± 0.5 vs. 6.6 ± 0.1 µmol⋅kg-1⋅min-1, P = 0.04).  
However, rates of glycogenolysis were not different between the two groups (0.4 ± 0.2 
vs. 0.8 ± 0.2 µmol⋅kg-1⋅min-1, P = 0.06). During re-feeding, rates of total glucose 
appearance, glucose production, gluconeogenesis and glycogenolysis were not different 











 Figure 3. Rates of glucose appearance, glucose production, gluconeogenesis and 
glycogenolysis in the non-lactating (  ) and the lactating  (  )  women following 14 h 
and 42 h of the fasting and 6 h of re-feeding. Values are mean ± SEM. All parameters are 
expressed as µmol·kg-1·min-1. All calculations are based on total body weight (kg). * P 




 Figure 4. Rates of appearance of leucine and urea and rates of proteolysis, protein 
oxidation and synthesis  in the non-lactating (  ) and  the lactating  (  ) women 
following 14 h and 42 h of the fasting and 6 h of re-feeding.  Values are mean ± SEM. 
All calculations are based on total body weight (kg). * P (non- paired) < 0.05, ** P (non- 
paired) < 0.01, controls (n = 6) vs. lactating (n = 6) women. 
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Protein kinetics. After an overnight fast, leucine Ra and accordingly, rates of proteolysis 
were not different between the two groups. Similarly, urea Ra and, thus protein oxidation 
rates, were not different between the non-lactating and the lactating women (Figure 4).  
After 42 h of fasting, rate of leucine appearance was higher in the lactating group (2.1 ± 
0.2 vs. 1.7 ± 0.1 µmol⋅kg-1⋅min-1, P < 0.05) and accordingly, the corresponding rate of 
proteolysis was higher in the lactating group (5.0 ± 0.4 vs. 4.0 ± 0.1g·kg-1·d-1, P < 0.05). 
Similarly, urea Ra (0.44 ± 0.02 vs. 0.33 ± 0.03 mg·kg-1·min-1, P < 0.05) and thus, rate of 
protein oxidation (1.9 ± 0.1 vs. 1.3 ± 0.1 g·kg-1·d-1, P < 0.05) were higher in the lactating 
group (Figure 4). During re-feeding, proteolysis, protein oxidation and synthesis were not 
different between the two groups. During the re-feeding period, proteolysis and protein 
synthesis rates increased (P < 0.05) when compared to the 42 h fasting in both the 
lactating and non-lactating groups, while, protein oxidation increased (P < 0.05) in the 
non-lactating group only (Figure 4).  
Energy expenditure and substrate oxidations. After an overnight fast, there was no 
difference in energy expenditure between the non-lactating and the lactating women. 
However, RQ and CHO oxidation were lower and fat oxidation was higher in the 
lactating group (Table 2). 
  After 42 h of fast, energy expenditure was not different between the lactating and 
the non-lactating women. However, RQ was lower (0.73 ± 0.01 vs. 0.79 ± 0.02, P < 0.01) 
and fat oxidation was higher (1.8 ± 0.2 vs. 1.2 ± 0.2 g·kg-1·d-1, P < 0.05) whereas that of 
CHO was lower (-0.2 ± 0.2 vs. 1.4 ± 0.5 g·kg-1·d-1, P < 0.01) in the lactating as compared 
to the non-lactating group. During the re-feeding, energy expenditure was also not 
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different between the two groups but fat oxidation remained higher (P < 0.05) and CHO 
oxidation remained lower (P < 0.05) in the lactating women. 
 
Table 2. Energy expenditure and substrate oxidation rates during fasting and re-feeding. 
 14 h-Fast 42 h-Fast Re-feeding 





RQ 0.85 ± 0.0 0.78 ± 0.0** 0.79 ± 0.0 0.73 ± 0.1** 0.81 ± 0.0 0.75 ± 0.0* 
EE     21 ± 1    21 ± 1    22 ± 1    24 ± 2    26 ± 1    27 ± 2 
Substrate oxidation rates (g·kg-1·d-1) 
Fat    0.8 ± 0.1   1.4 ± 0.1**   1.2 ± 0.2   1.8 ± 0.2*   1.2 ± 0.2   1.9 ± 0.24* 
CHO    2.3 ± 0.1    1.1 ± 0.3 **   1.4 ± 0.5  -0.2 ± 0.2**   1.8 ± 0.3   0.3 ± 0.5* 
Protein    1.1 ± 0.1 1.20 ± 0.1   1.1 ± 0.1   1.9 ± 0.2*   1.9 ± 0.1   1.8 ± 0.1 
 
Values are mean ± SEM. RQ = respiratory quotient; EE = Energy expenditure expressed 
as kcal·kg-1·d-1. * P (non- paired) < 0.05, ** P (non- paired) < 0.01, non-lactating (n = 5) 
vs. lactating (n = 5) women.  
 
 
   
Urine pH. Repeated measures ANOVA revealed differences over time (P < 0.001), 
differences between groups (non-lactating vs. lactating) (P < 0.001), and differences due 
to interaction of group and time (P < 0.001) (Table 3). Using Post Hoc comparisons, the 
pH of the urine collected during the first 24 h of fasting was not different between non-
lactating and lactating women. However, following 24 h of fasting, the pH was 
consistently lower in the lactating compared to the non-lactating (P < 0.01) women. From 
24 h to 42 h of fasting, the pH decreased (6.5 ± 0.2 vs.  4.7 ± 0.1, P < 0.01) in lactating 
women; while, it remained unchanged in the non-lactating women (6.7 ± 0.2 vs. 6.1 ± 
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0.3, P > 0.05). After re-feeding, the pH did not increase in either the lactating or the non-
lactating. However, it remained lower (P < 0.01)  in lactating women. 
 
Table 3. Urine pH in non-lactating and lactating women during fasting and re-feeding. 
Fasting time Non-lactating Lactating 
0-12 h 6.7 ± 0.2 a 6.5 ± 0.2a 
12-24 h 6.5 ± 0.1 a 5.9 ± 0.3a 
24-36 h 6.4 ± 0.3 a 5.3 ± 0.2 b 
36-42 h 6.1 ± 0.3 a 4.7 ± 0.1 c 
Re-feeding 6.3 ± 0.2 a 4.7 ± 0.1 c 
Values are mean ± SEM. Repeated measures ANOVA revealed differences over time (P 
< 0.001), differences between groups (non-lactating (n = 4) vs. lactating (n = 5)) (P < 
0.001), and differences due to interaction of group and time (P < 0.001). Different 
alphabets (based on Post Hoc comparisons) indicate significant difference (P < 0.05).  
 
 
Milk production and composition. After an overnight fast, milk volume was 99 ± 7 
ml/feeding (feeding represents 3h). The average milk productions reduced (P < 0.05) by 
14% (86 ± 8 ml/feeding) following 42 h fasting and was not increased after 6 h of re-
feeding (88 ± 8 ml/feeding) (Table 4). Milk protein and lactose concentrations were not 
different between fasting and re-feeding. The percentage of lactose hexoses derived from 
mammary gland synthesis after 14 h and 42 h of fasting were not different (45 ± 3 and 46 







Table 4. Milk production, composition and lactose hexoses derived from hexoneogenesis 
and plasma glucose during fasting and re-feeding.  
 14 h-Fast 42 h-Fast Re-feeding 
Milk volume  (ml/feed) 
          (ml/d)$ 
  99 ± 7a 
793 ± 55a 
  86 ± 8 b 
684 ± 68b 
   88 ± 8ab 
 704 ± 68ab 
Protein  Concentration (g/dl)  1.7 ± 0.2  1.9 ± 0.1   1.7 ± 0.3 
Lactose concentration (g/dl)  7.4 ± 0.3  6.5 ± 0.2   6.3 ± 0.2 
Milk glucose from Hexoneogenesis 
(%)   41 ± 4
a   40 ± 8a   -16 ± 5 
Milk galactose from Hexoneogenesis 
(%)   50 ± 3
a   52 ± 7a     -1 ±3 b 
Milk lactose from Hexoneogenesis 
(%)   45 ± 3
a   46 ± 8a     -8 ± 3 b 
Milk lactose from plasma glucose 
(%)   55 ± 3
a   54 ± 8a  109 ± 3b 
Milk lactose from Hexoneogenesis 
(µmol·kg-1·min-1) #  1.7 ± 0.1
a  1.4 ± 0.1b  -0.2 ± 0.1c 
Milk lactose  from plasma glucose 
(µmol·kg-1·min-1) ##  2.1 ± 0.1
a  1.6 ± 0.1b   3.2 ± 0.2c 
 
n = 6. Values are mean ± SEM. Paired t-test was used. Different alphabets within the 
same row indicate difference. Significance was set as P (paired) < 0.05. $ calculated by 
multiplying the milk volume (ml/feed) times 8 feeding/d. #   based on lactose derived 
from hexoneogenesis (%), milk volume and lactose concentration. ##  based on lactose 
derived from plasma glucose (%), milk volume and lactose concentration.     
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Discussion 
In our previous studies of 14-24 h fasting lactating women, the plasma substrate 
and hormone concentrations were similar in lactating and non-lactating women despite a 
30% increase in glucose demands in the lactating subjects. The increased glucose 
demands were met by increased rates of glycogenolysis (12, 30).  In the present study, we 
demonstrated that if the fast was merely extended by 18 h, the lactating women 
developed relative hypoglycemia, hyperketonemia and hyper free fatty acidemia when 
compared to the non-lactating controls.    
Plasma insulin and C-peptide followed the same pattern as glucose (i.e. decreased 
with the duration of fasting) in both groups whereas plasma glucagon concentrations 
increased progressively with the time of fasting plateauing after 30 h at  twice the basal 
concentrations in the lactating women. In the non-lactating women in the present study as 
well as in previously studied 3-day fasted women (9), plasma glucagon increased by only 
~50% from 14 h to 42 h of the fast. It is interesting to speculate, as has been done 
previously (9, 16), that the low plasma insulin and elevated glucagon may be the primary 
hormonal triggers to orchestrate the controlled mobilization of substrates, regulation of 
hepatic glucose production and substrate oxidation. 
In the present study, glucose production rate was 30% higher in the lactating 
compared to the non-lactating women after 14 h of fasting, results similar to those 
obtained following an overnight fasting (12) and 24 h of fasting (30). Extension of fasting 
to 42 h decreased glucose production rate by 30 and 40% in the non-lactating and 
lactating women, respectively, and was no longer different between the two groups. Rates 
of gluconeogenesis were, however, higher  at 42 h of fasting in the lactating women 
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contributing to 96 ± 1% of the glucose production as compared to 87 ± 3 % in the non-
lactating women. Thus, glycogenolysis accounted for a very minor part of the glucose 
production rate after 42 h fasting with no difference between non-lactating and lactating 
women. Our findings agree with those reported by Katz and Tayek (13), who reported 
that fractional gluconeogenesis increased from 41 to 92% between 12 and 40 h in fasting 
men. Similar results were reported by Landau et al (15). These observations suggest that 
after 42 h of fasting, hepatic glycogen stores are essentially depleted. This also would 
suggest that the higher rates of glycogenolysis in the lactating women resulted in earlier 
depletion of hepatic glycogen stores than in the non-lactating women. Therefore, after 42 
h of fasting, lactating women were relying nearly exclusively on gluconeogenesis for 
their glucose requirements.  
One potential mechanism to conserve maternal glucose during fasting is to 
increase the production of lactose from other substrates within the mammary gland. 
However, at 42 h of fasting, rates of mammary hexoneogenesis were not different from 
those observed following 14 h of fasting in the present study or 14-24 h of fasting in our 
previous studies (18, 28, 30). Calculating the minimum amount of lactose derived 
directly from plasma glucose, i.e. the amount that could not be contributed from 
hexoneogenesis (1.6 µmol·kg-1·min-1) (Table 4), we can calculate the approximate 
endogenous rate of glucose utilization in the lactating women. Thus, we estimated the 
rate of glucose utilization by maternal body tissues was lower in the lactating women (6.4 
± 0.4 vs. 7.4 ± 0.2 µmol·kg-1·min-1, P < 0.05). Even after 42 h of fasting, milk volume 
remained within the normal range reported previously (600-800 ml/d) (20) as did the 
composition of the aqueous macronutrients constituents. Therefore, even during extended 
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fasting, priority may be given to the delivery of nutrients to the mammary gland to 
support milk synthesis 
Concurrent to the increased gluconeogenesis in lactating women, following the 42 
h of fasting, β-hydroxybutyrate and FFA concentrations were higher than those of the 
non-lactating women reflecting higher rates of lipolysis and fat oxidation. Both the 
lactating and non-lactating women developed metabolic acidosis based on their ketosis. 
However, the lactating women were more acidotic as indicated by their higher plasma 
ketone body and FFA concentrations. This supposition is supported by the lower urine 
pH values in the lactating women. Metabolic acidosis increases renal ammoniagenesis as 
a mechanism to correct the metabolic acidosis (3, 6). Glutamine is the primary substrate 
for renal ammonia production while the carbon skeleton is incorporated into renal 
glucose production (6, 8, 21, 23). With extended fasting, the rate of proteolysis increased 
and, it is reasonable to speculate that the increased gluconeogenesis in the lactating 
compared to the non-lactating women may be attributed to the active contribution of 
renal gluconeogenesis. However, the increase in urea production in the lactating women 
might also indicate an increase in hepatic gluconeogenesis. Presumably both glycerol (24, 
26)  (a product of lipolysis) and amino acids (8, 17) provide the carbon needed for the 
hepatic gluconeogenesis. However, it is impossible to determine the veracity of this 
argument without considerably more invasive studies. Furthermore, indirect calorimetry 
data revealed that the lactating women had lower CHO and higher fat oxidation rates 
following both 42 h of fasting and re-feeding compared to the non-lactating women. 
Thus, the increased rates of gluconeogenesis and decreased rates of glucose utilization 
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and oxidation by maternal tissues, presumably by the higher availability of FFA and 
ketone bodies, conserved maternal glucose for milk lactose synthesis. 
After re-feeding, glucose concentrations increased and glucose production rates 
decreased in both groups with no difference between lactating and non-lactating women. 
Glucose production was almost entirely represented by gluconeogenesis, which was 
apparently decreased and corresponded to the 24 h fasting values previously reported in 
lactating and non-lactating women (30). FFA and β-hydroxybutyrate decreased with re-
feeding, but their concentrations remained higher in the lactating group. Despite re-
feeding for 6 h (a total of 50% of daily requirement), sources of energy utilization did not 
return to normal (i.e. after 14 h fast). The non-lactating women recovered more rapidly 
and shifted to CHO oxidation, whereas, lactating women continued to rely on both fat 
and protein as energy sources. Thus, all dietary CHO was most likely delivered to the 
mammary gland for milk production.  
With the ingestion of High Protein Boost® during the re-feeding period, the Ra of 
leucine (and thus the estimate of proteolysis) increased in both the lactating and non-
lactating women. This most likely does not reflect an increased rate of endogenous 
proteolysis since in our previous studies endogenous proteolysis decreases with feeding 
(1, 10, 27).  The increase in urea production rate (and thus protein oxidation) could be the 
result of oxidation of the protein consumed since 25% of the calories are provided as 
protein and/or this could be due to the incomplete equilibration of the urea tracer over the 
6 h period of the study.  In the non- lactating women, the increase in protein oxidation 
rate was consistent with an increase in the rate of proteolysis of the dietary protein. 
However, the increase in proteolysis in the lactating women during re-feeding was not 
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associated with a further increase in protein oxidation suggesting that the dietary amino 
acids might be more readily utilized for protein synthesis, e.g. body tissue and/or milk 
proteins. 
In summary, both the non-lactating and lactating women adapted to a 42 h fast by 
reducing endogenous glucose needs by similar mechanisms. However, due to the added 
demands imposed by lactation, the metabolic stress was greater in the lactating women as 
indicated by lowered glucose concentration, increased glucagon concentrations, 
decreased utilization of CHO, higher plasma concentrations of FFA and ketone bodies 
(presumed greater metabolic acidosis), and higher plasma concentrations and rates of 
urea production, which presumably reflect increased rates of amino acid deamination and 
availability of carbon to support the increased rate of gluconeogenesis.   
The present study concluded that the lactating women as compared to the non-
lactating women are at risk for fasting hypoglycemia if fasting is extended. Although 
milk production and composition were preserved, fasted lactating women were more 
acidotic and subjected to protein loss as reflected by increased proteolysis and protein 
oxidation and fat loss as indicated by increased fat mobilization and oxidation. 
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